| Dr Matthew Riley, MD | |
|
1340 Hal Greer Blvd, Huntington, WV 25701-3804 | |
| (304) 526-2200 | |
| (304) 399-1507 |
| Full Name | Dr Matthew Riley |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 5 Years |
| Location | 1340 Hal Greer Blvd, Huntington, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871052761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 32383 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center-pineville | Charlotte, NC | Hospital |
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Cabell Huntington Hospital Inc | Huntington, WV | Hospital |
| Atrium Health University City | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cabell Huntington Hospital Inc | 3274436340 | 68 |
News Archive
An anti-vaccination group that has been in the news for all the wrong reasons recently has been stripped of its charitable status after the state government found its fund raising appeals had not been conducted in good faith. The Australian Vaccination Network (AVN) came into news when in July it was ordered to publish a disclaimer on its website stating the group was anti-vaccination and its material should not be read as medical advice.
Geriatrics experts know that certain medications may have risks for older adults that outweigh their benefits, especially when safer alternatives are available.
Scientists at the Gladstone Institute of Neurological Disease (GIND) have discovered that two main causes of AD amyloid-beta (Aβ) peptides and apolipoprotein E4 (apoE4) impair the growth of new neurons born in adult brains. What is more, they have identified drug treatments that can normalize the development of these cells even in the presence of Aβ or apoE4. The findings are described in two separate papers published in the current issue of Cell Stem Cell.
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
› Verified 4 days ago
| Entity Name | Cabell Huntington Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275576373 PECOS PAC ID: 3274436340 Enrollment ID: O20040128000461 |
News Archive
An anti-vaccination group that has been in the news for all the wrong reasons recently has been stripped of its charitable status after the state government found its fund raising appeals had not been conducted in good faith. The Australian Vaccination Network (AVN) came into news when in July it was ordered to publish a disclaimer on its website stating the group was anti-vaccination and its material should not be read as medical advice.
Geriatrics experts know that certain medications may have risks for older adults that outweigh their benefits, especially when safer alternatives are available.
Scientists at the Gladstone Institute of Neurological Disease (GIND) have discovered that two main causes of AD amyloid-beta (Aβ) peptides and apolipoprotein E4 (apoE4) impair the growth of new neurons born in adult brains. What is more, they have identified drug treatments that can normalize the development of these cells even in the presence of Aβ or apoE4. The findings are described in two separate papers published in the current issue of Cell Stem Cell.
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Riley, MD 1340 Hal Greer Blvd, Huntington, WV 25701-3804 Ph: (304) 526-2200 | Dr Matthew Riley, MD 1340 Hal Greer Blvd, Huntington, WV 25701-3804 Ph: (304) 526-2200 |
News Archive
An anti-vaccination group that has been in the news for all the wrong reasons recently has been stripped of its charitable status after the state government found its fund raising appeals had not been conducted in good faith. The Australian Vaccination Network (AVN) came into news when in July it was ordered to publish a disclaimer on its website stating the group was anti-vaccination and its material should not be read as medical advice.
Geriatrics experts know that certain medications may have risks for older adults that outweigh their benefits, especially when safer alternatives are available.
Scientists at the Gladstone Institute of Neurological Disease (GIND) have discovered that two main causes of AD amyloid-beta (Aβ) peptides and apolipoprotein E4 (apoE4) impair the growth of new neurons born in adult brains. What is more, they have identified drug treatments that can normalize the development of these cells even in the presence of Aβ or apoE4. The findings are described in two separate papers published in the current issue of Cell Stem Cell.
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
› Verified 4 days ago
William E Walker, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1540 Spring Valley Drive, Va Medical Center, Huntington, WV 25704 Phone: 304-429-6741 | |
Dr. Jared Lucas Ross, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1340 Hal Greer Blvd, Huntington, WV 25701 Phone: 304-526-2200 Fax: 304-399-1507 | |
Barry Burchett, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 612 6th Ave, Huntington, WV 25701 Phone: 304-525-4202 Fax: 304-525-4231 | |
Dr. Anna Katherine Corbin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2585 3rd Ave, Huntington, WV 25703 Phone: 304-781-5138 Fax: 304-781-5139 | |
Dr. Lee Van Horn, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Center Dr Ste 1500, Huntington, WV 25701 Phone: 304-691-1100 | |
Timothy M Daly, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 1st Ave, Huntington, WV 25702 Phone: 304-526-1436 | |
David John Whitmore, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 Hal Greer Blvd, Huntington, WV 25701 Phone: 304-525-0572 |